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4.1  Antioxidant Capacity
The generation of reactive oxygen species (ROS) and other free radicals during 
metabolism is an essential and normal process that ideally is compensated through 
the antioxidant system. However, due to many environmental, lifestyle, and patho-
logical situations, free radicals and oxidants can be produced in excess, resulting in 
oxidative damage of biomolecules (e.g., lipids, proteins, and DNA). This plays a 
major role in the development of chronic and degenerative illness such as cancer, 
autoimmune disorders, aging, cataract, rheumatoid arthritis, cardiovascular, and 
neurodegenerative diseases (Pham-Huy et al. 2008; Willcox et al. 2004). The human 
body has several mechanisms to counteract oxidative stress by producing 
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antioxidants, which are either naturally synthetized in situ, or externally supplied 
through foods, and/or supplements (Pham-Huy et al. 2008).
Research indicates that foods rich in antioxidants such as honey can protect from 
the damaging effects of free radicals and ROS and thus exhibit beneficial effects on 
human health; such as cardiovascular protection by preventing ROS-induced low 
density lipoprotein (LDL) oxidation (Schramm et al. 2003); cell death in some cancer 
cell lines (Jaganathan et al. 2015); enhance the human antioxidant defense system 
(Schramm et al. 2003) among others (Ajibola 2015). For instance in animal models, 
honey showed a protective effect against damage and oxidative stress induced by 
cigarette smoke in rat testis (Mohamed et al. 2011); honey supplementation exhibited 
a hepatoprotective and nephroprotective effect in rats with experimental aflatoxicosis 
due to its antioxidant activity (Yaman et al. 2016).
The antioxidant capacity (or antioxidant activity) of honey is commonly attrib-
uted to its phenolic compounds. These compounds exhibit several preventive effects 
against different diseases like cancer, cardiovascular diseases, inflammatory disor-
ders, neurological degeneration, wound healing, infectious diseases and aging 
(Khalil et al. 2010).
The main antioxidant phenolic compounds in honey are: (a) phenolic acids: gal-
lic acid, caffeic, ellagic, ferulic and p-coumaric acids, syringic acid, benzoic acid, 
cinnamic acid; chlorogenic acid, and (b) flavonoids: apigenin, chrysin, galangin, 
hesperetin, kaempferol, pinocembrin and quercetin (Fig.  4.1) (Rao et  al. 2016; 
Erejuwa et al. 2014). While some of these bioactive compounds are found in most 
honey samples, others such as hesperetin and naringenin are found in few honey 
varieties (Erejuwa et al. 2012).
The amount and type of the phenolic antioxidants depend largely upon the hon-
ey’s floral source and/or variety of the honey (Gheldof et al. 2002). Generally, darker 
honeys have been shown to have a higher total phenolic content (TPC) and conse-
quently a higher antioxidant capacity than lighter honeys (Eteraf-oskouei and Najafi 
2013). Beside this, Ferreira et al. (2007) found that the dark honey contained the 
highest concentration of other antioxidants such flavonoids, ascorbic acid, and 
β-carotene compared to the light and amber honeys.
In addition, some in vivo studies have shown that the antioxidant compounds of 
honey are bioavailable to the human body. Schramm et  al. (2003) observed that 
honey fed at 1.5 g/kg body weight increased both phenolic antioxidants and plasma 
antioxidant capacity inhealthy human subjects. These results supported the concept 
that phenolic antioxidants from honey are bioavailable and that these compounds 
may augment oxidative defense in the human body. Similar evidence has was 
observed by (Gheldof et al. 2003).
The antioxidant activity of phenolic compounds is related to a number of different 
mechanisms, such as free radical-scavenging, hydrogen-donation, singlet oxygen 
quenching and/or metal ion chelation (Eteraf-oskouei and Najafi 2013). Therefore, in 
order to obtain more accurate and representative results, the antioxidant capacity of 
honey is generally measured by use of various in vitro assays such as: in the form of 
antiradical activity using 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenging assay; 
2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) assay; oxygen radi-
cal absorbance capacity (ORAC) assay; and commonly used  ferric reducing antioxi-
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dant power (FRAP) assay, that measures the conversion by  antioxidants of the oxidized 
form of iron (Fe3+) to the reduced form (Fe2+) (Erejuwa et al. 2012). Several in vitro 
studies showed that the antioxidant capacity is strongly correlated with the content of 
the total phenolics in honey (Chua et al. 2013; Sagdic et al. 2013). For instance, a posi-
tive correlation was found between antioxidant capacity (ORAC assay) and TPC of 
various commercial honeys contributed to their antioxidant properties.
However, Gheldof et al. (2002) stated that the levels of single phenolic or other 
compounds in honey are too low to have a major individual antioxidant significance. 
Hence, the total antioxidant capacity of honey has been associated to the result of 
the combined activity and interactions of a wide range of compounds, including 
both enzymatic: catalase, glucose oxidase, peroxidase and non-enzymatic sub-
stances: ascorbic acid, α-tocopherol, carotenoids, amino acids, proteins, organic 
acids, Maillard reaction products, and other minor components (Nayik et al. 2016; 
Eteraf-oskouei and Najafi 2013; Ferreira et al. 2007).
Erejuwa et al. (2012) described the synergistic antioxidant effect of honey and 
thus considered the advantage of honey over other antioxidants, such as vitamins C 
and E. In fact, these vitamins in their antioxidant action do not end with scavenging 
or elimination of free radicals. Instead, they can become themselves pro-oxidants 
which can require other antioxidants for their regeneration into the active or antioxi-
dant form. The advantage of honey is that it comprises several antioxidant constitu-
ents and if any of them exhibit pro-oxidant properties, there would be sufficient 
other antioxidants, which can protect the one against oxidative destruction, and thus 
lead to the regeneration into the antioxidant form. In fact, honey contains both aque-
ous and lipophilic antioxidants and thus can act at different cellular levels as an 
ideal natural antioxidant (Oryan et al. 2016).
Moreover, the quantity of honey consumed in the diet is low compared with the 
quantity of many of the food sources of antioxidants. According to (Erejuwa et al. 
2012), if honey would be used instead of refined sugars as a sweetener for food and 
drinks it could make a substantial difference to the quantity of antioxidants con-
sumed in the diet.
4.2  Antibacterial Activity
The treatment of bacterial infections is being increasingly complicated by the ability of 
bacteria to develop resistance to current available antimicrobial agents. This evidence 
leads to the need of less and better use of antibacterials and antifungals, improved 
infection control and research on new therapeutic compounds (Feás et al. 2013).
Antibacterial activity of honey is one of the most important findings that was first 
recognized in 1892 by the Dutch scientist Van Ketel (Eteraf-oskouei and Najafi 
2013). The recent research indicates that the effectiveness of honey in many of its 
medical uses is due to its antibacterial activity that is capable of inhibiting Gram- 
positive and Gram-negative bacteria, including multidrug resistant strains (Kwakman 
et al. 2008), and some species of fungi and viruses (Irish et al. 2006; Naama 2009).
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For instance, Junie et al. (2016) compared in vitro antibacterial activity of several 
types of honey of different origins against the bacterial resistant strains isolated 
from patients, including Pseudomonas aeruginosa, Escherichia coli, Staphylococcus 
aureus, Staphylococcus epidermidis, Salmonella enterica serovar Typhimurium, 
Bacillus cereus, Bacillus subtilis, and Listeria monocytogenes. The results showed 
that all the honey samples presented antibacterial activity against the studied strains 
and that all the honey samples inhibited bacterial growth. This evidence was similar 
to other studies conducted elsewhere (Huttunen et al. 2013).
The quantitative determination of the reduction of microbial colonization against 
a representative panel of bacteria is generally analyzed by in vitro tests including (a) 
determination of minimum inhibitory concentration (MIC) using broth tube dilution 
methods through visual inspection and (b) by determination of minimum bacteri-
cidal concentration (MBC) by sub-culturing tubes showing no visible sign of growth/
turbidity (Wasihun and Kasa 2016); these determinations allow a distinction between 
whether a honey is just stopping the bacteria from growing (bacteriostatic action) or 
is killing the bacteria (bactericidal action), respectively (Molan 1992). It has been 
stated that honey possessed a significant antibacterial activity against some bacteria 
which are resistant to antibiotics (Junie et al. 2016; Mohapatra et al. 2011).
In a study by Wasihun and Kasa (2016) the antibacterial activity of honey was 
evaluated against multidrug resistant human pathogenic bacterial isolates 
(Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Proteus mirabi-
lis, coagulase-negative Staphylococcus, Streptococcus pyogenes and Klebsiella pneu-
moniae). The MIC and MBC values indicated that the tested honeys had potential 
bacteriostatic and bactericidal activities against the tested bacteria. Unlike most con-
ventional antibiotics, honey dose may not lead to development of antibiotic- resistant 
bacteria and it may be used continuously (Eteraf-oskouei and Najafi 2013). According 
to Alandejani et  al. (2009), antibiotics tested (cefazolin, oxacillin, vancomycin, 
azithromycin, fusidic acid, gentamicin, and linezolid) were not bactericidal to methi-
cillin-sensitive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus 
(MRSA), or Pseudomonas aeruginosa (PA) biofilms. But the bactericidal rates for the 
Sidr and Manuka honeys were significantly higher than those seen with the single 
antibiotics. Thus, the use of honey in a medical setting is considered to be helpful in 
combating bacterial resistance (Kwakman et al. 2008).
The bacterial strains differ in their sensitivity to honeys. Due to the different floral 
source, locations, bee species, storage (time and temperature), and processing, the 
antibacterial potency of different honeys can vary (Grego et al. 2016; Sousa et al. 
2016), for some by more than 100-fold (Lusby et al. 2005). Thus it is difficult to 
standardize honeys and assess their usefulness in a medical application (Sousa et al. 
2016). In spite of this, there are medical grade honeys like Revamil source (RS) 
honey and Manuka (i.e., Medihoney). Having reproducible antibacterial activity, 
these honeys are produced under controlled conditions in greenhouses and each 
batch is analyzed individually to assess the Unique Manuka Factor (UMF) that gives 
a number based on its bactericidal activity (Knight 2013).
However, the mechanism by which honey exerts the activities against a broad 
spectrum of organisms is still under debate. There are some factors that are closely 
related to the antibacterial capacity of honey, including the level of hydrogen perox-
4 Honey Health Benefits and Uses in Medicine
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ide (H2O2), which is formed when honey is diluted (Knight 2013). According to 
Hadagali and Chua (2014), enzymes convert sucrose into a simple and soluble mix-
ture of monosaccharides. The sugar molecules in the honey solution bind to free 
water molecules (Fig. 4.2), which means that there is no water available for microbes 
to use, preventing their survival. The enzyme glucose oxidase (produced by bees) 
converts glucose into gluconic acid, making the honey too acidic for microbes to 
grow and survive. The H2O2 produced as a by-product of this reaction acts as a spo-
ricidal antiseptic that sterilizes the honey (Fig. 4.3).
Further, the osmolarity of honey, due to about 80% of its composition being sug-
ars, is another important factor to prevent growth of bacteria (Kwakman and Zaat 
2012). Different concentrations (or dilutions) of honey used in the in vitro tests have 
been associated with a different antibacterial response (Steinberg et al. 1996).
Beside the sugar content, the low pH (between 3.2 and 4.5 for undiluted honey) 
is inhibitory to many pathogenic bacteria. However, when consumed orally, the 
honey would be so diluted by body fluids that any effect of low pH is likely to be 
lost (Molan 1995). In spite, honeys have substantial antibacterial activity due to 
non-peroxide components including methylglyoxal and the antimicrobial peptide 
bee defensing-1. For instance, these compounds have been identified in Manuka and 
RS honey as antibacterial compounds (Kwakman and Zaat 2012). In addition, fac-
Sugar Molecules
Honey
Water Molecules
Fig. 4.2 Physical structure 
of honey (Hadagali and 
Chua 2014)
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tors such as phenolic compounds (i.e. flavonoids and phenolic acids) (Kwakman 
and Zaat 2012; Sousa et al. 2016) and some unknown floral or bee components are 
being considered as contributing to the antibacterial activity of honey as well 
(Nishio et al. 2016).
4.3  Anti-inflammatory Capacity
Honey possesses quite a large number of therapeutic properties, including antioxi-
dant and antimicrobial properties, as well as anti-inflammatory activity (Vallianou 
et al. 2014).
The anti-inflammatory property of honey is mainly related to its antiseptic nature 
that works by removing infectious bacteria stimulating the inflammatory response, 
and reduction of the amount of bacteria present in the wound (Hadagali and Chua 
2014). In fact, that honey can remove bacteria that cause inflammation, a decrease in 
wound inflammation after applying honey gauze has been associated to its direct 
anti-inflammatory properties, such as antioxidant capacity (Yaghoobi et al. 2013). In 
particular, some of the antioxidant phenolic compounds (i.e. flavonoids) are deeply 
related to anti-inflammatory effects as previously reported in the literature (González 
et al. 2011). However, beside the wound inflammation (Tomblin et al. 2014), the 
correlation of antioxidant capacity of honey with its anti-inflammatory action has 
been observed in other inflammation models as well (Owoyele et al. 2011).
For instance, the potential protective effect of a honey flavonoid extract (HFE) has 
been studied on the production of pro-inflammatory mediators by lipopolysaccharide- 
stimulated N13 microglia. It has been shown that the HFE (containing luteolin, quer-
cetin, apigenin, kaempferol, isorhamnetin, acacetin, tamarixetin, chrysin, and 
galangin) can inhibit microglial activation and thus be considered as a potential pre-
ventive−therapeutic agent for neurodegenerative diseases involving neuroinflamma-
tion (Candiracci et  al. 2012). The main evidence that considers the antioxidant 
activity as the anti-inflammatory factor is the ability of antioxidants to inhibit ROS 
production during the inflammatory process. A number of drugs are available for the 
treatment of ulcerative colitis. Manuka honey has been shown to specifically decrease 
the inflammatory response associated with ulcerative colitis, an inflammatory bowel 
disease characterized by an over-expression of inflammatory cells, possibly by 
Glucose
Enzyme
Gluconic acid
(pH~3.5)
glucose oxidase
H2O2
(Antiseptic)
Too acidic for microbes Sterilizes the honey
Suppress the microbial growth when honey is applied to a wound
+
Fig. 4.3 Formation of gluconic acid and hydrogen peroxide (H2O2) (Hadagali and Chua 2014)
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increasing antioxidant activity (Prakash et  al. 2008). In a study by Borsato et  al. 
(2014), honey extract decreased edema, reduced leucocyte infiltration, and inhibited 
the production of ROS during the inflammatory process induced chemically in mice 
ear. The anti-inflammatory activity has been associated with a synergetic effect of the 
honey phenolic compounds, including kaempferol and caffeic acid.
In general, the transcription factor nuclear factor-kappa beta (NF-KB) plays a key 
role in pathogenesis of inflammation, being known as marker of inflammation 
(Vallianou et al. 2014). It enhances pro-inflammatory activity, thereby contributing to 
an amplified inflammatory response, and activates genes encoding pro- inflammatory 
cytokines – interleukin (IL)-6, IL-8, and tumor necrosis factor-α (TNF-α). These pro-
inflammatory cytokines stimulate nitric oxide production (NO), an important media-
tor of inflammation (Tomblin et al. 2014).
The anti-inflammatory effect of honey has been observed in numerous reports, stat-
ing that honey can inhibit the release of pro-inflammatory cytokines, expression of nitric 
oxide synthase (iNOS), production of ROS (Candiracci et al. 2012), and can decreases 
prostaglandin levels, one of the major players in the process of inflammation (Al-Waili 
and Boni 2003). According to an in vivo study by Owoyele et al. (2011), honey caused 
inhibition of NO release in acute and chronic inflammation. Further, Gelam honey has 
been investigated in an acute inflammation model system showing the reduction of 
edema in inflamed rat paws. The mechanism was associated with the inhibition of cyclo-
oxygenase (COX-2) and iNOS, which resulted in suppressed levels of pro-inflammatory 
mediators such as NO, PGE2, TNF-α, and IL-6 (Hussein et al. 2012).
In general, acute inflammation is the body’s primary response to injurious stimuli, 
and some of the body’s responses are characterized by pains (Hadagali and Chua 
2014). Side effects of the available drugs for the treatment of inflammatory pain can 
sometimes limit the use of these drugs (e.g., NSAID, Indomethacin) (Owoyele et al. 
2014). It has been shown that honey significantly decreased production of pro-
inflammatory cytokines, which was similar to the effect of the anti- inflammatory 
drug Indomethacin (NSAID) (Hussein et al. 2012), and also could modulate musca-
rinic receptors to produce its analgesic effect (Owoyele et  al. 2014), thus being 
potentially useful for treatment of inflammation.
4.4  Wound Healing Activity
Several animal studies and clinical trials have examined the application of honey for 
acute and chronic wounds (Moore et  al. 2001) including burn injuries (Bangroo 
et al. 2005), and have demonstrated that it limits the amount of edema, improves 
granulation and epithelization in the proliferative phase while decreasing total 
wound healing time, reduces scarring and contractures in patients with burn wounds 
(Mohamed et al. 2015), without adverse effect (allergy or toxicity) at all (Yaghoobi 
et al. 2013). Due to its low adherence in wound surface, honey causes minimal pain 
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during application and upon removal preserving the newly forming granulation tis-
sue (Mohamed et al. 2015).
There is evidence that honey can heal partial thickness burns more quickly 
(around 4–5 days) than conventional dressings; and post-operative infected wounds 
can be treated by honey more effectively than by use of antiseptic or gauze (Jull 
et al. 2008). In a study by (Mohamed et al. 2015), a total of 12 patients with chronic 
foot ulcers utilized natural honey as an effective alternative to more expensive, 
advanced wound products. After the wound rinsing with normal saline, natural 
honey was applied and the wound was covered by glycerin-impregnated gauze. 
Patients were followed on a daily basis for an average of 4 weeks (Fig. 4.4). The 
results showed that all ulcers healed with no contractures or scars with a mean heal-
ing time of 3 weeks. Moreover, there was a 75% reduction in the dressing budget of 
the health center and a high level of satisfaction among both health professionals 
and patients. Also, patients’ pain levels were reduced significantly after using natu-
ral honey. Similar evidence has been observed when Manuka honey gel was used 
for treatment of partial-thickness facial burns. The healing time was congruent with 
or better than what would been expected with standard treatment. No abnormal 
bacterial growth was reported and the patients reported overall satisfaction with the 
treatment and cost of the treatment. It has been suggested that Manuka honey is a 
clinically and economically valuable treatment for partial-thickness facial burns 
a
d e
b c
a b c
Fig. 4.4 Wound healing activity of honey. Case 1 (a–e): Diabetic neuropathic ulcer with 3 weeks 
time to healing. Case 2: (a–c): Varicose ulcer with 6 weeks time to healing (Mohamed et al. 2015)
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(Duncan et al. 2016). In addition, a recent study by Aziz et al. (2017) showed that 
honey dressings can promote better results for burn wounds than the silver-based 
dressings (i.e., silver sulfadiazine), the currently extensively used method used to 
treat a variety of acute and chronic wounds.
The presence of antibiotic resistant S. aureus in wounds is a cause for concern 
due to its capacity to acquire resistance to multiple antibiotics that make the 
treatment of wounds difficult. Jenkins et  al. (Jenkins et  al. 2012) showed that 
Manuka honey effectively inhibited the strains of vancomycin-intermediate S. 
aureus (hVISA, VISA) and the clinical strains of vancomycin-sensitive S. aureus 
(VSSA) in the clinical setting. It has been indicated that Manuka honey at low 
concentration (≤6% (w/v)) can inhibit the growth of clinical isolates of S. aureus 
and thus can be used as a treatment option to help decontaminate wounds infected 
with antibiotic- resistant organisms like S. aureus. Besides that, clinical and labo-
ratory data indicate that natural honey is effective against a variety of common 
pathogens (see Sect. 4.2).
Honey facilitates wound healing by its ability to create an effective viscous 
barrier on the wound surface, thus preventing the invasion of microorganisms 
(Aziz et al. 2017) present in the wounds and can remove any dead tissue that may 
provide a favourable environment for the growth of microorganisms (Zbuchea 
2014). The acidic pH of honey (3.2 to 4.5) inhibits growth of most pathogenic 
bacteria within wounds, and increases production of hydrogen peroxide from the 
enzyme glucose oxidase at 1:1000 concentration. This is less than the conven-
tional rinse solutions but enough to inhibit bacterial growth without compromis-
ing the new granulation tissue (Mohamed et  al. 2015). Thus, when applied 
topically, honey is capable of cleaning infection from a wound and improving 
healing (Al-waili et al. 2011). Nevertheless, the wound healing capacity of honey 
is not only through its antiseptic nature, but also through its immunomodulatory 
effects, which boost the immune system to fight infection (Fig.4.4). The compo-
nents in honey related to its immunomodulatory properties have not been yet 
fully identified, but are being attributed to lipopolysaccharide (LPS), a 5.8 kDa 
component, major royal jelly protein 1, arabinogalactants, polyphenols, and anti-
oxidants (McLoone et al. 2016). Different types of honey have been shown to act 
with different mechanisms, and moreover that some of these mechanisms are 
more efficient than others (Ranzato et al. 2013). For instance, buckwheat honey 
is used in wound healing products because of its high- polyphenolic content, 
which make this honey effective in reducing ROS levels causing cell damage and 
inhibition of wound healing; Manuka honey has notable antibacterial and healing 
activities, which directly originate from the methylglyoxal it contains, and make 
this honey useful for treating problematic wounds (Ranzato et  al. 2013). The 
Manuka honey has been claimed to have therapeutic advantages over other hon-
eys and is thus the type of honey most often studied in controlled wound healing 
studies (Majtan 2011) (Fig. 4.5).
The honey for wound healing is being commonly used as a base for ointments, gels, 
and in surgical dressings (Shenoy et al. 2012) and some studies successfully demon-
strated its healing effect when applied directly in a raw form (Mohamed et al. 2015). 
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However, natural honey from the comb is not medical grade and should not be used in 
wound care. Medical grade honey is filtered; gamma irradiated to kill Clostridium 
spores, and produced under exacting standards of hygiene. There are some commer-
cially available sterile honey products like Revamil source (RS) and Manuka honey, the 
two major medical-grade honeys.
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